A61K 38/1738
Calcium binding proteins
Official title: {Calcium binding proteins, e.g. calmodulin}
A61K38/1738 (Calcium binding proteins) appears on 40 US grants and 71 published applications in this corpus.
Search patents in A61K- Granted patents
- 40
- Published applications
- 71
- Assignees
- 52
- Inventors
- 159
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 3 |
| 2006 | 0 | 2 |
| 2007 | 2 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 5 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 1 | 4 |
| 2014 | 2 | 2 |
| 2015 | 0 | 3 |
| 2016 | 6 | 5 |
| 2017 | 0 | 2 |
| 2018 | 0 | 2 |
| 2019 | 3 | 4 |
| 2020 | 3 | 7 |
| 2021 | 3 | 10 |
| 2022 | 5 | 4 |
| 2023 | 3 | 3 |
| 2024 | 2 | 4 |
| 2025 | 2 | 1 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modulation of mTORCI activity and autophagy via CIB2-RHEB interaction23 Jun 2026US 12,661,385 B2University of Maryland, Baltimore
- Compositions for diagnosis, prevention, or treatment of fatty liver disease19 May 2026US 12,630,879 B2Hysensbio
- Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)13 May 2025US 12,295,985 B2The Schepens Eye Research Institute, Inc.
- Pharmaceutical composition for prevention or treatment of heart failure4 Feb 2025US 12,215,362 B2Bethphagen Inc.
- Method for preparing a bone protein preparation and a bone protein preparation24 Sep 2024US 12,097,243 B2Bbs-Bioactive Bone Substitutes Oyj
- S100A1 Protein for use in Treating and Preventing Infarct Extension27 Aug 2026US 2026/0248885 A1
- Engineered Ligand promotes TREM1-dependent anti-tumor immunity through cross-presentation12 Mar 2026US 2026/0069658 A1National Yang Ming.Chiao Tung University
- Use of recombinant calreticulin in hair growth, hair breeding, hair protection or anti-hair loss and related product2 Jan 2025US 2025/0000944 A1Beijing Yitubaihui Biotech Co., Ltd
- Annexin to inhibit bacteria19 Sep 2024US 2024/0307488 A1University of Virginia Patent Foundation
- Methods and compositions for administering otoferlin dual vector systems19 Sep 2024US 2024/0309399 A1Decibel Therapeutics, Inc.
Most cited
By later US patents
- Materials and methods for making improved micelle compositions92US 6,217,886 B1The Board of Trustees of the University of Illinois · 2001
- Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity56US 5,945,452 AThe Board of Trustees of the Leland Stanford Junior University · 1999
- Methods and compositions for treating ocular disorders10US 6,855,690 B2Children's Medical Center Corporation · 2005
- Modulation of efferocytosis pathways for treatment of atherosclerotic disease8US 10,329,354 B2The Board of Trustees of the Leland Stanford Junior University · 2019
- Methods and compositions useful in the treatment of mucositis7US 8,497,243 B2Promedior, Inc. · 2013